Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Natsumi Fukuhara has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Katsuyuki Hoshina

    Department of Vascular Surgery, The University of Tokyo, Tokyo, Japan

    2 shared publications
  • F. Ikuta

    Department of Internal Medicine (Dr. Tanno), National Sanatorium Nishi-Ojiya Hospital, Ojiya; the Departments of Neurology (Drs. Tanno, Yoneda, Tanaka, Kondo, Hozumi. and Tsuji) and Pathology (Drs. Wakabayashi, Yamada, and Ikuta), Brain Research Institute, Niigata University, Niigata; and the Department of Neurology (Dr. Fukuhara), National Saigata Hospital, Oogata-machi, Japan

    1 shared publication
  • Isao Hozumi

    Laboratory of Medical Therapeutics and Molecular Therapeutics, Department Biomedical Pharmaceutics, Gifu Pharmaceutical University, Gifu City, Japan

    1 shared publication
  • K. Wakabayashi

    Department of Internal Medicine (Dr. Tanno), National Sanatorium Nishi-Ojiya Hospital, Ojiya; the Departments of Neurology (Drs. Tanno, Yoneda, Tanaka, Kondo, Hozumi. and Tsuji) and Pathology (Drs. Wakabayashi, Yamada, and Ikuta), Brain Research Institute, Niigata University, Niigata; and the Department of Neurology (Dr. Fukuhara), National Saigata Hospital, Oogata-machi, Japan

    1 shared publication
  • Kazuhiro Miyahara

    Division of Vascular Surgery, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

    1 shared publication
  • Kazuyoshi Matsubara

    Division of Vascular Surgery, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

    1 shared publication

Latest Publications

  • Open Access

    Specific Features of Patients Under 40 Years Old With Small-to-Medium-Sized Arterial Deterioration

    by Kazuyoshi Matsubara, Natsumi Fukuhara, Katsuyuki Hoshina, Kazuhiro Miyahara, Masamitsu Suhara, Ryosuke Taniguchi, Mitsuru Matsukura, Toshio Takayama

    Background: Arterial deterioration is mostly caused by atherosclerosis, which progresses with age. However, we have observed serious backgrounds or etiologies in younger patients with non-atherosclerotic diseases and deterioration of small-to-medium-sized arterial lesions. Therefore, we aimed to identify the specific features of patients aged P = 0.011). Furthermore, the data analysis of patients with multiple arterial lesions (≥3) revealed that the younger population tended to have more specific backgrounds or etiologies, notably Ehlers-Danlos syndrome and Behçet's disease. There were no differences in the all-cause mortality and cardiovascular disease-related mortality between patients aged P = 0.89 and 0.29, respectively).Conclusions: Over 50% of patients aged <40 years with deterioration of small-to-medium-sized arteries had non-atherosclerotic, specific clinical backgrounds or etiologies, including genetic and inflammatory diseases. In addition, they exhibited more arterial lesions than older patients.


  • Open Access

    Efficient Suppression of Abdominal Aortic Aneurysm Expansion in Rats through Systemic Administration of Statin-Loaded Nanomedicine

    by Natsumi Fukuhara, Yuto Honda, Nao Ukita, Makoto Matsui, Yutaka Miura, Katsuyuki Hoshina

    Abdominal aortic aneurysm (AAA) is a life-threatening disease. However, no systemically injectable drug has been approved for AAA treatment due to low bioavailability. Polymeric micelles are nanomedicines that have the potential to improve therapeutic efficacy by selectively delivering drugs into disease sites, and research has mainly focused on cancer treatments. Here, we developed a statin-loaded polymeric micelle to treat AAAs in rat models. The micelle showed medicinal efficacy by preventing aortic aneurysm expansion in a dose-dependent manner. Furthermore, the micelle-injected group showed decreased macrophage infiltration and decreased matrix metalloproteinase-9 activity in cases of AAA.


  • Uniform tissue distribution of tRNA Lys mutation in mitochondrial DNA in MERRF patients

    by Y. Tanno, M. Yoneda, K. Tanaka, R. Kondo, I. Hozumi, K. Wakabayashi, M. Yamada, N. Fukuhara, F. Ikuta, S. Tsuji

    We documented the presence of a point mutation in the tRNA(Lys) gene of mitochondrial DNA (mtDNA) in various postmortem tissues from two patients with myoclonus epilepsy associated with ragged-red fibers (MERRF). The percentages of the mutant mtDNA were similar (93 to 99%) in both clinically affected and unaffected tissues, suggesting that preferential clinical involvement of certain tissues in MERRF is based not only on the variation of distribution of the mutant mtDNA, but also on other factors such as differences in the threshold in various CNS regions and organs.